The Second Affiliated Hospital ZUSM

What The Second Affiliated Hospital ZUSM does

The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) is a public, state-owned academic medical center headquartered in Hangzhou, Zhejiang Province, China, affiliated with Zhejiang University School of Medicine and tracing its origin to 1869 as Hangzhou Guangji Hospital. Operating across 8 campuses (with two additional campuses under construction as of May 2026), the hospital runs approximately 4,000 beds and 7,000 medical staff including 2,839 physicians in 50+ clinical departments and 3,845 nurses. SAHZU serves a domestic patient base drawn from Zhejiang Province and surrounding regions as well as international patients via a dedicated International Medicine Department at the Binjiang Campus; referral cases flow in from lower-tier hospitals, and medical trainees (Chinese and international) participate in fellowship, residency, and elective programs.

The hospital's clinical portfolio is organized around eight named Centers of Excellence — Heart, Cancer, Eye, Brain, Orthopedic, Emergency, Transplantation, and Pulmonary — with 10 specialties ranked in the national top 10 by the Fudan University Best Chinese Hospital Ranking 2023, including Rare Disease (#2) and Emergency Medicine (#4). SAHZU holds A++++ accreditation and ranks top 4 nationally in the National Health Commission's Tertiary Hospital Performance Evaluation 2023, and was the first JCI-accredited academic medical center in China (2013, reaccredited through 2022). The institution has produced peer-reviewed research in Nature, Cell, Science, and the Lancet family, including the NOVAtria heart failure device, an engineered dendritic cell immunotherapy (iCDC), and the LEAF photosynthesis-based dry eye treatment.

Revenue is generated through regulated clinical services (outpatient, inpatient, surgical, emergency), per-visit international medicine services with direct insurance billing, professional-services revenue from medical education and training programs, and subscription-style health management services. Distribution is hybrid: multi-campus in-person care across Hangzhou, online booking via website and Alipay mini-program, telemedicine (SAHZU Telemedicine and UCLA Teleconsultation), and an international channel network anchored by direct billing partnerships, Belt and Road outreach, and proctoring activities in Hong Kong and Central/Southeast Asia. AI capability is delivered through strategic partnerships — notably with Alibaba DAMO Academy (medical AI) and Yitu Technology (AI-enabled CT) — and through in-house research into novel therapeutics, devices, and immunology.

Name

The Second Affiliated Hospital ZUSM

Legal name

The Second Affiliated Hospital Zhejiang University School of Medicine

Website

https://en.z2hospital.com

Company type

Private

Founded year

1869

Operating status

Operating

Headcount range

1–10 employees

Short description

The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) is a public academic medical center in Hangzhou, China, operating 8 campuses with 4,000 beds and 7,000 staff across 50+ clinical departments, serving domestic patients, international patients, and medical trainees with tertiary and quaternary care.

Ownership category

akta.pro rank

Product category

Tertiary Academic Hospital Services

NAICS

General Medical and Surgical Hospitals (622110), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Tertiary hospital services
• Academic medical center
• Specialty clinical care
• International patient services
• Medical education training

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Services Revenue: Patient care services including outpatient consultations, inpatient treatments, surgical procedures, and emergency services across 50+ clinical departments.
2. International Patient Services: Specialized services for international patients including dedicated International Medicine Department, concierge support, and direct billing partnerships with insurance companies.
3. Medical Education and Training: Fellowship training, residency programs, medical student electives, and nursing student electives for both Chinese and international healthcare workers.
4. Health Management Services: Preventive health services and health management programs as part of their ranked specialty in health management (#5 nationally).

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

SAHZU is a comprehensive tertiary academic medical center delivering specialized clinical care across 50+ clinical departments organized into eight Centers of Excellence (Heart, Cancer, Eye, Brain, Orthopedic, Emergency, Transplantation, Pulmonary) operating from 8 campuses with about 4,000 beds and 7,000 staff. It also provides international patient services with multilingual concierge support, telemedicine and UCLA teleconsultation, and medical training programs (fellowships, residencies, electives) for domestic and foreign healthcare professionals.

Product overview

The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) is a comprehensive academic medical center operating 8 campuses with approximately 4,000 beds and 7,000 medical staff. The hospital offers a portfolio of medical services including specialized Centers of Excellence (Heart, Cancer, Eye, Brain, Orthopedic, Emergency, Transplantation, Pulmonary), digital health services (SAHZU Telemedicine, SAHZU Internet Hospital with bilingual services, SAHZU Good Doctor mini-program on Alipay), and the International Medicine Department for serving international patients. SAHZU provides telemedicine consultations including UCLA teleconsultation and patient referral, general consultation services across 50+ clinical departments, and international training programs for medical professionals.

Differentiator

Problem solved

Functional benefit

Products and services

• Centers of Excellence (Heart, Cancer, Eye, Brain, Orthopedic, Emergency, Transplantation, Pulmonary)
• International Medicine Department
• SAHZU Telemedicine
• UCLA Teleconsultation and Patient Referral
• SAHZU Internet Hospital
• General Consultation Services
• International Training Programs (Fellowship, Residency, Medical Student Elective, Nursing Student Elective)

Quantifiable outcome

• 9.72 million outpatient and emergency visits annually
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability11 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Alibaba DAMO AcademycoreTechnology or Integration · 3 June 2026Strategic partnership to jointly advance medical AI development and clinical translation. Focus areas include cardiovascular disease screening, malignant tumor diagnosis, pathology agents, medical image analysis, and dynamic health management. Aims to develop innovative medical AI algorithms and translate research findings into clinical applications.
• National University of SingaporecoreStrategic or Co-development Partner · 21 May 2026Collaborative research on photosynthesis-based dry eye treatment. SAHZU Eye Center and NUS jointly developed the LEAF nanotechnology using spinach-derived thylakoids for treating dry eye disease through light-driven cellular reactions.
• Hangzhou-based Medical Technology CompanycoreTechnology or Integration · 21 April 2026Co-development of DragonFly transcatheter edge-to-edge repair (TEER) device for mitral regurgitation treatment. Device successfully used in proctoring procedures at Chinese University of Hong Kong.
• University of California Los Angeles (UCLA)coreStrategic or Co-development PartnerSAHZU-UCLA Academic Center for Diagnosis offering teleconsultation and patient referral services. International collaboration for medical knowledge exchange and remote diagnostic support.
• French National Institute of Health and Medical Research (INSERM)coreStrategic or Co-development PartnerJoint laboratory in ultrasound medicine accredited as Zhejiang Provincial International Joint Laboratory in 2024. Collaborative research in ultrasound imaging and biomedical engineering.
• Chinese University of Hong Kong (CUHK)coreStrategic or Co-development PartnerClinical collaboration on transcatheter edge-to-edge repair (TEER) procedures. SAHZU team proctored procedures at CUHK Faculty of Medicine. Both sides expressed interest in deepening collaboration combining clinical resources and industrial capacity with Hong Kong's international platform for translational research.
• Kazakh Institute of Oncology and RadiologyminorStrategic or Co-development PartnerAcademic exchange and collaboration under Belt and Road Initiative framework. Dr. Yan Xiaobo delivered keynote lecture and performed decompression surgery alongside local surgeons.
• Malaysian Medical InstitutionsminorStrategic or Co-development PartnerInternational medical cooperation under Belt and Road Initiative. Prof. Ye Zhaoming performed bone tumor resection surgery in Malaysia and fostered bilateral medical exchange.
• International Insurance CompaniescoreChannel Partner/ Reseller/ DistributorDirect billing partnerships with major insurance companies enabling international patients to access services without upfront payment. List of direct billing partners updated regularly.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Huashan Hospital Affiliated to Fudan University: Premier Shanghai-based academic medical center under Fudan University. Comparable as a top-ranked tertiary teaching hospital with strong specialty rankings (especially neurosurgery and infectious disease) and international patient programs.
• The First Affiliated Hospital of Zhejiang University: Zhejiang University's flagship hospital located in the same city (Hangzhou) as SAHZU. Most direct local comparable, competing for the same regional tertiary referrals, talent, and research funding under the same university system.
• The First Affiliated Hospital of Sun Yat-sen University: Top-tier Southern China academic medical center in Guangzhou. Comparable as a comprehensive tertiary teaching hospital with strong specialty rankings, research output, and international engagement.
• Ruijin Hospital, Shanghai Jiao Tong University School of Medicine: Historic Shanghai academic medical center with strong specialty rankings and research output. Comparable as a top-tier public tertiary teaching hospital with comprehensive specialty centers and international collaborations.
• West China Hospital of Sichuan University: Largest single-site hospital in the world by bed count and a top-ranked Chinese academic medical center. Direct comparable in scale (~4,000+ beds), research output, and tertiary referral profile in a different geographic region.
• Tongji Hospital, Huazhong University of Science and Technology: Top-ranked Central China academic medical center in Wuhan with comprehensive specialty coverage and large patient volume. Comparable as a major public tertiary teaching hospital affiliated with a leading Chinese university.
• Zhongshan Hospital, Fudan University: Major Shanghai academic medical center with nationally ranked cardiology, oncology, and other specialties. Comparable in scale, public ownership, and tertiary referral profile.
• Peking Union Medical College Hospital (PUMCH): China's most prestigious academic medical center under the Chinese Academy of Medical Sciences. Direct comparable as a top-tier tertiary public teaching hospital with national rankings, comprehensive specialty coverage, and international patient services.

Broad incumbents

• Mayo Clinic: Premier US-based integrated academic medical center. Comparable as a top-tier global destination for complex tertiary care with strong specialty rankings, research output, and international patient services — representing SAHZU's aspirational global benchmark.
• Cleveland Clinic: Major US-based multi-specialty academic medical center with global brand and international patient services. Comparable as a globally recognized tertiary referral destination with strong specialty programs and digital/telemedicine initiatives.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCcCb27cGsA8bgQSVyZPY6JA
• Facebookfacebook.com/SAHZU.CHINA
• Instagraminstagram.com/SAHZU.CHINA
• LinkedInlinkedin.com/company/sahzu

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Second Affiliated Hospital ZUSM